A, C., M, D. M., O, N., A, L., DL, C., JG, A., . . . DJ, P. (2021). Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. Journal for immunotherapy of cancer, 9(4), . https://doi.org/10.1136/jitc-2021-002421
Chicago Style (17th ed.) CitationA, Cortellini, et al. "Differential Influence of Antibiotic Therapy and Other Medications on Oncological Outcomes of Patients with Non-small Cell Lung Cancer Treated with First-line Pembrolizumab Versus Cytotoxic Chemotherapy." Journal for Immunotherapy of Cancer 9, no. 4 (2021). https://doi.org/10.1136/jitc-2021-002421.
MLA (9th ed.) CitationA, Cortellini, et al. "Differential Influence of Antibiotic Therapy and Other Medications on Oncological Outcomes of Patients with Non-small Cell Lung Cancer Treated with First-line Pembrolizumab Versus Cytotoxic Chemotherapy." Journal for Immunotherapy of Cancer, vol. 9, no. 4, 2021, https://doi.org/10.1136/jitc-2021-002421.
